Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - DEPRECIATION & AMORTIZATION
Depreciation & Amortization EXEL - Exelixis, Inc.
28.8 M
LAST VALUE
17.46%
2 YEAR CAGR
28.11%
5 YEAR CAGR
28.26%
10 YEAR CAGR